دورية أكاديمية

Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts.

التفاصيل البيبلوغرافية
العنوان: Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts.
المؤلفون: Menn-Josephy, Hanni, Lee, Carol S., Nolin, angela, Christov, Marta, Rybin, Denis V., Weinberg, Janice M., Henderson, Joel, Bonegio, Ramon, Havasi, andrea
المصدر: American Journal of Nephrology; Oct2016, Vol. 44 Issue 4, p289-299, 11p, 4 Charts, 4 Graphs
مصطلحات موضوعية: KIDNEY disease treatments, AGE distribution, BIOPSY, CHRONIC kidney failure, DIABETIC nephropathies, HEMODIALYSIS, KIDNEYS, KIDNEY diseases, PROGNOSIS, RESEARCH funding, TIME, FIBROSIS, PREDICTIVE tests, RETROSPECTIVE studies, DISEASE progression, DISEASE complications
مستخلص: Background: The extent of interstitial fibrosis on kidney biopsy is regarded as a prognostic indicator and guide to treatment. Patients with extensive fibrosis are assigned to supportive treatments with the expectation that they have advanced beyond the point at which immunosuppressive or other disease-modifying therapies would be of benefit. Our study highlights some of the limitations of using interstitial fibrosis to predict who will develop end-stage renal disease (ESRD).Methods: Analysis of 434 consecutive renal biopsies performed between 2001 and 2012 at a single center. We assessed the influence of various clinical factors along with fibrosis as predictors of ESRD and dialysis-free survival in various patient groups.Results: Interstitial fibrosis performed well overall as a predictor of progression to dialysis. On average, patients with >50% fibrosis progressed more rapidly than those with either 25-49 or 0-24% fibrosis with a median time to dialysis of 1.2, 6.5 and >10 years, respectively. In contrast, interstitial fibrosis was of less value as a predictor of disease progression in a subset of cases that included patients over the age of 70 and those with diabetic nephropathy on biopsy. Surprisingly, 13.9% of patients with normal renal function had 25-49% fibrosis and 5% had more than 50% fibrosis on biopsy, and 5 years after undergoing biopsy 21% of patients with >50% fibrosis still remained dialysis free.Conclusion: Renal fibrosis is an imperfect prognostic indicator for the development of ESRD and caution should be exercised in applying it too rigidly, especially in elderly or diabetic patients. [ABSTRACT FROM AUTHOR]
Copyright of American Journal of Nephrology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:02508095
DOI:10.1159/000449511